Celyad Oncology SA (CYAD)

US1512052002 - ADR

0.47  -0.06 (-11.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022
Revenue
YoY % growth
5K
-16.67%
EBITDA
YoY % growth
-15.145M
44.10%		-24.87M
-64.21%		-4.333M
82.58%
EBIT
YoY % growth
-16.977M
41.21%		-26.39M
-55.45%		-5.773M
78.12%
Operating Margin
-339,540.00%N/AN/A
EPS
YoY % growth
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2017
Q2Q % growth		 -4.30 -1.54-2.76-179.18%
Q2 2016
Q2Q % growth		 -1.82
13.33%		-1.920.105.09%
Q4 2015
Q2Q % growth		 -1.33 -1.810.4826.33%
Q2 2015
Q2Q % growth		 -2.10 -1.91-0.19-10.10%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2017
Q2Q % growth		 561K 561K∞%
Q2 2017
Q2Q % growth		 3.505M 3.505M∞%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A